These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31979298)

  • 21. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
    Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
    Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triple stimuli-responsive keratin nanoparticles as carriers for drug and potential nitric oxide release.
    Li Y; Lin J; Zhi X; Li P; Jiang X; Yuan J
    Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():606-614. PubMed ID: 30033293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo.
    Chen WL; Yang SD; Li F; Qu CX; Liu Y; Wang Y; Wang DD; Zhang XN
    Acta Biomater; 2018 Nov; 81():219-230. PubMed ID: 30267887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GSH/pH dual-responsive biodegradable camptothecin polymeric prodrugs combined with doxorubicin for synergistic anticancer efficiency.
    Li J; Hu ZE; Yang XL; Wu WX; Xing X; Gu B; Liu YH; Wang N; Yu XQ
    Biomater Sci; 2019 Aug; 7(8):3277-3286. PubMed ID: 31180396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arginine-α, β-dehydrophenylalanine Dipeptide Nanoparticles for pH-Responsive Drug Delivery.
    Singh PK; Chibh S; Dube T; Chauhan VS; Panda JJ
    Pharm Res; 2018 Jan; 35(2):35. PubMed ID: 29362936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimuli-responsive hybrid cluster bombs of PEGylated chitosan encapsulated DOX-loaded superparamagnetic nanoparticles enabling tumor-specific disassembly for on-demand drug delivery and enhanced MR imaging.
    Xie P; Du P; Li J; Liu P
    Carbohydr Polym; 2019 Feb; 205():377-384. PubMed ID: 30446118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poly(ethylene glycol) shell-sheddable TAT-modified core cross-linked nano-micelles: TAT-enhanced cellular uptake and lysosomal pH-triggered doxorubicin release.
    Zhang Y; Xiao Y; Huang Y; He Y; Xu Y; Lu W; Yu J
    Colloids Surf B Biointerfaces; 2020 Apr; 188():110772. PubMed ID: 31999965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of surface functionalized hydroxyapatite nanoparticles for enhanced specificity towards tumor cells.
    Verma G; Shetake NG; Pandrekar S; Pandey BN; Hassan PA; Priyadarsini KI
    Eur J Pharm Sci; 2020 Mar; 144():105206. PubMed ID: 31870813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AIE/FRET-based versatile PEG-Pep-TPE/DOX nanoparticles for cancer therapy and real-time drug release monitoring.
    Wang TT; Wei QC; Zhang ZT; Lin MT; Chen JJ; Zhou Y; Guo NN; Zhong XC; Xu WH; Liu ZX; Han M; Gao JQ
    Biomater Sci; 2020 Jan; 8(1):118-124. PubMed ID: 31777865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: preparation, in vitro and in vivo evaluation.
    Li Q; Lv S; Tang Z; Liu M; Zhang D; Yang Y; Chen X
    Int J Pharm; 2014 Aug; 471(1-2):412-20. PubMed ID: 24905776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear targeting peptide-modified, DOX-loaded, PHBV nanoparticles enhance drug efficacy by targeting to Saos-2 cell nuclear membranes.
    Şahin A; Eke G; Buyuksungur A; Hasirci N; Hasirci V
    J Biomater Sci Polym Ed; 2018 Apr; 29(5):507-519. PubMed ID: 29297759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base.
    Li F; Zheng C; Xin J; Chen F; Ling H; Sun L; Webster TJ; Ming X; Liu J
    Int J Nanomedicine; 2016; 11():3875-90. PubMed ID: 27574421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapeutic Delivery from a Self-Assembling Peptide Nanofiber Hydrogel for the Management of Glioblastoma.
    Karavasili C; Panteris E; Vizirianakis IS; Koutsopoulos S; Fatouros DG
    Pharm Res; 2018 Jun; 35(8):166. PubMed ID: 29943122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. pH-triggered morphological change in a self-assembling amphiphilic peptide used as an antitumor drug carrier.
    Gong Z; Liu X; Wu J; Li X; Tang Z; Deng Y; Sun X; Chen K; Gao Z; Bai J
    Nanotechnology; 2020 Apr; 31(16):165601. PubMed ID: 31891937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced antitumor efficacy of arginine modified amphiphilic nanoparticles co-delivering doxorubicin and iSur-pDNA via the multiple synergistic effect.
    Song Y; Tang C; Yin C
    Biomaterials; 2018 Jan; 150():1-13. PubMed ID: 29028548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
    Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X
    Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. pH and redox dual-sensitive polysaccharide nanoparticles for the efficient delivery of doxorubicin.
    Yang S; Tang Z; Zhang D; Deng M; Chen X
    Biomater Sci; 2017 Sep; 5(10):2169-2178. PubMed ID: 28914292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Redox-responsive nanocarriers for drug and gene co-delivery based on chitosan derivatives modified mesoporous silica nanoparticles.
    Lin JT; Liu ZK; Zhu QL; Rong XH; Liang CL; Wang J; Ma D; Sun J; Wang GH
    Colloids Surf B Biointerfaces; 2017 Jul; 155():41-50. PubMed ID: 28407530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
    Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
    Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.